BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10631434)

  • 1. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
    Barry PW
    Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434
    [No Abstract]   [Full Text] [Related]  

  • 2. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
    Tibballs J; Goh TH; McKenzie I; Hochmann M
    Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension.
    Max M; Kuhlen R; Dembinski R; Rossaint R
    Intensive Care Med; 1999 Oct; 25(10):1147-54. PubMed ID: 10551974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching the ideal inhaled vasodilator: from nitric oxide to prostacyclin.
    Kemming G; Habler O; Kleen M; Kisch-Wedel H; Welte M; Zwissler B
    Eur Surg Res; 2002; 34(1-2):196-202. PubMed ID: 11867923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation.
    Fiser SM; Cope JT; Kron IL; Kaza AK; Long SM; Kern JA; Tribble CG; Lowson SM
    J Thorac Cardiovasc Surg; 2001 May; 121(5):981-2. PubMed ID: 11326243
    [No Abstract]   [Full Text] [Related]  

  • 6. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
    Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
    Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
    Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized prostacyclins.
    Siobal M
    Respir Care; 2004 Jun; 49(6):640-52. PubMed ID: 15165299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.
    Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH
    J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of inhaled nitric oxide with aerosolized prostacyclin or analogues for the postoperative management of pulmonary hypertension: a systematic review and meta-analysis.
    Chen SH; Chen LK; Teng TH; Chou WH
    Ann Med; 2020; 52(3-4):120-130. PubMed ID: 32204626
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Delivery of inhaled aerosolized prostacyclin (IAP).
    van Heerden PV; Power BM; Leonard RC
    Anaesth Intensive Care; 1996 Oct; 24(5):624-5. PubMed ID: 8909691
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled Therapies for Pulmonary Hypertension.
    Hill NS; Preston IR; Roberts KE
    Respir Care; 2015 Jun; 60(6):794-802; discussion 802-5. PubMed ID: 26070575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with ARDS.
    Dahlem P
    Intensive Care Med; 1999 Dec; 25(12):1474-5. PubMed ID: 10660861
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
    Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
    Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandins in patients with pulmonary hypertension: the route of administration.
    Booke M; Van Aken H; Theilmeier G; Meyer J
    Anesth Analg; 1998 Apr; 86(4):917. PubMed ID: 9539630
    [No Abstract]   [Full Text] [Related]  

  • 17. Administration of Inhaled Pulmonary Vasodilators to the Mechanically Ventilated Neonatal Patient.
    Davis MD; Donn SM; Ward RM
    Paediatr Drugs; 2017 Jun; 19(3):183-192. PubMed ID: 28374138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
    J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide combined with prostacyclin and adrenomedullin in acute respiratory failure with pulmonary hypertension in piglets.
    Dani C; Pavoni V; Corsini I; Longini M; Gori G; Giannesello L; Perna A; Gritti G; Paternostro F; Forestieri A; Buonocore G; Rubaltelli FF
    Pediatr Pulmonol; 2007 Nov; 42(11):1048-56. PubMed ID: 17902148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.